Fig. 5.
TPO levels in plasma of untreated control (2) and transgenic mice (5) in the 4 days after the stopping of GCV treatment. For the transgenic mice, high levels of TPO were found when the platelet count and the MK mass were severely decreased.
TPO levels in plasma of untreated control (2) and transgenic mice (5) in the 4 days after the stopping of GCV treatment. For the transgenic mice, high levels of TPO were found when the platelet count and the MK mass were severely decreased.
